Skip to main content
HR 5587 113th Congress House Health Congressional oversight Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Drug, alcohol, tobacco use Education programs funding Emergency medical services and trauma care Government studies and investigations Health care coverage and access Health care quality Health information and medical records Health personnel Health programs administration and funding Health promotion and preventive care Medical education Medical ethics Medical tests and diagnostic methods Prescription drugs Solid waste and recycling

Opioid Abuse Prevention and Treatment Act of 2014

Introduced: September 18, 2014 Introduced by: Foster, Bill Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 19, 2014
Referred to the Subcommittee on Health.
Sep 18, 2014
Referred to the House Committee on Energy and Commerce.
Sep 18, 2014
Introduced in House
 Plain-English summary Congressional Research Service

Opioid Abuse Prevention and Treatment Act of 2014 - Requires the Secretary of Health and Human Services (HHS) to award grants to states to develop a peer review process to identify and investigate questionable or inappropriate prescribing and dispensing patterns of drugs classified as schedule II or III under the Controlled Substances Act, which are drugs with an accepted medical use that have the potential to be abused and addictive.

Amends the Public Health Service Act to require the Secretary to establish grant programs to: (1) facilitate training to increase the capacity of health care providers to screen and treat patients to prevent drug abuse, and (2) develop continuing education criteria that allow health profession boards or state agencies to certify appropriate education for safe prescribing of schedule II or III drugs. Requires the Administrator of the Health Resources and Services Administration to award grants to evaluate the prospect of state health professions boards expanding the authority of providers to prescribe drugs to treat drug abuse.

Requires the Attorney General to request that practitioners registered to dispense controlled substances screen patients for potential drug abuse before prescribing a schedule II or III drug.

Directs the Food and Drug Administration (FDA) to consider whether naloxone (a prescription drug used to rapidly reverse an overdose of heroin or other opioids, which are drugs with effects similar to opium) should be available without a prescription.

Requires the Secretary to use an interagency working group to encourage states and local governments to increase opportunities for disposal of opiates (drugs derived from opium) and to reduce opportunities for abuse of opiates.

Requires the Government Accountability Office (GAO) to review federal opioid abuse activities and make recommendations to reduce opioid abuse and overdoses.
What's happening now September 19, 2014

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2